HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome.

Abstract
The purpose of this study was to assess the phenotypic and functional characteristics of pulmonary microvascular endothelial cells (MVEC) in the acute respiratory distress syndrome (ARDS). Pulmonary MVEC were isolated from the lungs of five patients who developed ARDS, and from four patients who had undergone a lobectomy for lung carcinoma, as controls. Adhesion molecules and other surface molecules were quantitated on these cells by flow cytometry and the cytokines IL-6 and IL-8 were measured in the supernatants by ELISA. The constitutive expression of intercellular adhesion molecule and, to a lesser extent, vascular adhesion molecule-1, was significantly increased on MVEC isolated from all ARDS patients, as compared with control MVEC. CD14 and TNF receptor p75 were also increased on the surface of MVEC isolated from most patients with ARDS. The expression of ELAM-1 and TNF receptor p55 (TNF-R1) was not significant on the surface of either ARDS-derived or control pulmonary MVEC. The constitutive ability of ARDS-derived MVEC to secrete IL-6 and IL-8 was markedly enhanced as compared with control MVEC. Upon in vitro restimulation by TNF, pulmonary MVEC from ARDS patients showed lower ICAM-1 upregulation, but similar IL-6 and IL-8 production capacity, when compared with control MVEC. Selective differences were found in cell adhesion molecules and TNF receptor p75 expression on pulmonary MVEC isolated from patients with ARDS. These pulmonary MVEC spontaneously overexpress some adhesion molecules and produce greater amounts of the pro- and anti-inflammatory cytokines IL-8 and IL-6. These findings suggest that ICAM-1 and TNF receptor p75 may have a particular involvement in the pathogenesis of acute lung injury, and that the endothelium may be an important source of cytokines detected in broncho-alveolar lavage during this syndrome. It is tempting to hypothesize that the differences observed result from either a genetic predisposition to ARDS based on MVEC phenotype or to a long-lived MVEC phenotypic change induced by ARDS. By allowing the monitoring of phenotypic and functional parameters, cultures of pulmonary MVEC isolated from ARDS patients may thus represent a useful system to analyze further the mechanisms of acute lung injury and to evaluate the efficacy of drugs, including inhibitors of cytokines and of adhesion molecules.
AuthorsG E Grau, N Mili, J N Lou, D R Morel, B Ricou, R Lucas, P M Suter
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 74 Issue 4 Pg. 761-70 (Apr 1996) ISSN: 0023-6837 [Print] United States
PMID8606486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • E-Selectin
  • Interleukin-6
  • Interleukin-8
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • Intercellular Adhesion Molecule-1
Topics
  • Adult
  • Animals
  • E-Selectin (analysis)
  • Endothelium, Vascular (physiopathology)
  • Female
  • Humans
  • Intercellular Adhesion Molecule-1 (analysis)
  • Interleukin-6 (biosynthesis)
  • Interleukin-8 (biosynthesis)
  • Lipopolysaccharide Receptors (analysis)
  • Lipopolysaccharides (pharmacology)
  • Lung (blood supply, physiology)
  • Male
  • Mice
  • Middle Aged
  • Phenotype
  • Receptors, Tumor Necrosis Factor (analysis)
  • Respiratory Distress Syndrome (physiopathology)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • Vascular Cell Adhesion Molecule-1 (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: